Lipid Droplets Are Beneficial for Rabies Virus Replication by Facilitating Viral Budding

J Virol. 2022 Jan 26;96(2):e0147321. doi: 10.1128/JVI.01473-21. Epub 2021 Nov 10.

Abstract

Rabies is an old zoonotic disease caused by rabies virus (RABV), but the pathogenic mechanism of RABV is still not completely understood. Lipid droplets (LDs) have been reported to play a role in pathogenesis of several viruses. However, their role in RABV infection remains unclear. Here, we initially found that RABV infection upregulated LD production in multiple cells and mouse brains. After treatment with atorvastatin, a specific inhibitor of LDs, RABV replication in N2a cells decreased. Then we found that RABV infection could upregulate N-myc downstream regulated gene-1 (NDRG1), which in turn enhanced the expression of diacylglycerol acyltransferase 1/2 (DGAT1/2). DGAT1/2 could elevate cellular triglyceride synthesis and ultimately promote intracellular LD formation. Furthermore, we found that RABV-M and RABV-G, which were mainly involved in the viral budding process, could colocalize with LDs, indicating that RABV might utilize LDs as a carrier to facilitate viral budding and eventually increase virus production. Taken together, our study reveals that lipid droplets are beneficial for RABV replication, and their biogenesis is regulated via the NDRG1-DGAT1/2 pathway, which provides novel potential targets for developing anti-RABV drugs. IMPORTANCE Lipid droplets have been proven to play an important role in viral infections, but their role in RABV infection has not yet been elaborated. Here, we find that RABV infection upregulates the generation of LDs by enhancing the expression of N-myc downstream regulated gene-1 (NDRG1). Then NDRG1 elevated cellular triglycerides synthesis by increasing the activity of diacylglycerol acyltransferase 1/2 (DGAT1/2), which promotes the biogenesis of LDs. RABV-M and RABV-G, which are the major proteins involved in viral budding, could utilize LDs as a carrier for transport to cell membrane, resulting in enhanced virus budding. Our findings will extend the knowledge of lipid metabolism in RABV infection and help to explore potential therapeutic targets for RABV.

Keywords: N-Myc downstream-regulated gene 1; biogenesis; diacylglycerol acyltransferase; lipid droplets; rabies virus; viral budding.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anticholesteremic Agents / pharmacology
  • Atorvastatin / pharmacology
  • Cell Cycle Proteins / genetics
  • Cell Cycle Proteins / metabolism
  • Diacylglycerol O-Acyltransferase / metabolism
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Lipid Droplets / drug effects
  • Lipid Droplets / metabolism*
  • Mice
  • Neurons / metabolism
  • Neurons / virology
  • Rabies / metabolism
  • Rabies / virology*
  • Rabies virus / drug effects
  • Rabies virus / physiology*
  • Triglycerides / metabolism
  • Viral Structural Proteins / metabolism
  • Virus Release* / drug effects
  • Virus Replication* / drug effects

Substances

  • Anticholesteremic Agents
  • Cell Cycle Proteins
  • Intracellular Signaling Peptides and Proteins
  • N-myc downstream-regulated gene 1 protein
  • Triglycerides
  • Viral Structural Proteins
  • Atorvastatin
  • Diacylglycerol O-Acyltransferase